obesity
Endocrinology · 2023–2023
1decision
1medicine
1carried consumer input
104individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| semaglutide Chronic weight management in adults with class III obesity (BMI ≥40 kg/m²) and at least two weight-related comorbidities, including a confirmed diagnosis of… | Nov 2023 | Not recommended | 104 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.